KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
In January 2010 the International Accounting Standards Board published a limited scope exposure draft on the measurement of liabilities, which should be of significant interest to companies in the extractive industries.
Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.